Buy Skyrizi Pre-fill Cartridge w/ Injector Online

Skyrizi Pre-fill Cartridge w/ Injector contains risankizumab-rzaa, a biologic medicine used as maintenance treatment after induction therapy for certain inflammatory conditions, including moderate to severe Crohn’s disease in adults. You can buy Skyrizi Pre-fill Cartridge w/ Injector and choose the strength shown during ordering to match your clinician’s directions. The Crohn’s maintenance presentation includes a 360 mg/2.4 mL prefilled cartridge used with an on-body injector.

The on-body injector is designed for subcutaneous use, meaning the medicine is delivered under the skin. It is not intended for immediate symptom relief during an acute flare. Treatment decisions should stay aligned with your diagnosis, prior therapies, lab monitoring, vaccination history, and the instructions provided by your healthcare professional.

Skyrizi On-Body Injector Price and Strength Selection

Current Canadian pricing for Skyrizi Pre-fill Cartridge w/ Injector is shown during ordering, including the available strength and quantity. The Skyrizi on-body injector 360 mg/2.4 mL price can vary with the quantity supplied, market conditions, and pharmacy service fees. If you are budgeting without insurance, review the displayed cost before placing the order so the maintenance schedule and refill timing are clear.

The Crohn’s disease maintenance format uses the prefilled cartridge with the on-body injector, rather than a clinic infusion. Other Skyrizi presentations may be used for different labeled conditions, such as plaque psoriasis or psoriatic arthritis, and may involve different devices. Match the form and strength to the directions you received, especially if you have used an induction dose or another Skyrizi device in the past.

Quick tip: Keep a written record of your dose date, device type, and next planned refill so maintenance doses are easier to plan.

How to Order and Plan Refills

Order Skyrizi online by selecting the listed strength and quantity, then following the checkout steps. Our order process may include reviewing treatment and medication details before the medicine is supplied through licensed pharmacies. For temperature-sensitive medicines, packaging and handling steps are used to help protect the product in transit, and US delivery from Canada may be available for appropriate orders.

Plan refills several weeks before your next scheduled maintenance dose. Biologic therapies can require coordination because they are costly, temperature-sensitive, and tied to a fixed treatment interval. If your dose date changes, or if you have recently switched from IV induction to the on-body injector, confirm the timing with your care team before arranging the next supply.

What This Medicine Treats

Skyrizi is an interleukin-23 inhibitor. IL-23 is an immune signaling protein involved in inflammatory pathways. Risankizumab-rzaa binds to the p19 subunit of IL-23, helping reduce inflammatory activity associated with certain immune-mediated diseases. In Crohn’s disease, the prefilled cartridge with on-body injector is used for maintenance after the labeled intravenous induction regimen.

This treatment is used in adults with moderately to severely active Crohn’s disease when it is clinically appropriate. Skyrizi is also associated with labeled uses in plaque psoriasis and psoriatic arthritis, although those conditions may use other device formats. If you are reviewing therapy by condition, the internal summaries for Crohn’s disease, psoriasis, and psoriatic arthritis can help you organize questions for your clinician.

Because this medicine changes immune signaling, it is usually considered when disease activity, prior treatment response, safety history, and treatment goals support biologic therapy. It should not be started during an active serious infection. People with a history of tuberculosis, chronic infections, or recurrent infections may need evaluation and monitoring before and during therapy.

Cartridge, On-Body Injector, and Device Differences

The Skyrizi 360 mg cartridge with injector is a maintenance device combination for Crohn’s disease. The cartridge holds the medicine, and the on-body injector controls delivery after the cartridge is loaded. The device attaches to clean, intact skin and administers the dose under the skin while you limit movement during delivery.

A prefilled syringe is different from the on-body injector format. With a syringe, the user or caregiver manually performs the injection. With the on-body injector, the device automates delivery after setup and activation. Skyrizi pen and syringe presentations may be associated with other labeled uses, so device names should not be used interchangeably unless your clinician has specifically directed that format.

Searches for Skyrizi 150 mg/mL pen price or Skyrizi 150 mg syringe cost often relate to different presentations. If your treatment plan calls for Crohn’s maintenance dosing, focus on the 360 mg/2.4 mL cartridge with on-body injector and the schedule written for you. If the device on your paperwork differs from the product you intend to purchase, clarify before use.

How the On-Body Injector Is Used

The on-body injector should be used only after you have been trained in the injection technique and device steps. General preparation includes taking the carton out of the refrigerator as directed, inspecting the cartridge and injector, choosing a clean injection site, and avoiding damaged or irritated skin. Do not shake the cartridge, and do not use the device if it appears damaged or the medicine does not look as described in the official instructions.

Typical application sites include the abdomen or thigh, following the Instructions for Use. The cartridge is loaded into the device, the injector is applied to the skin, and the dose is started according to the device prompts. Manufacturer instructions note that the injection should be started within the specified time after inserting the cartridge into the on-body injector. During delivery, avoid pressing on, bumping, or removing the device early.

The device provides indicators that help show progress and completion. The full delivery process takes several minutes, and the device should remain in place until the dose is complete. If the injector stops early, falls off, leaks, or shows an error, contact your healthcare professional for next steps rather than trying to repeat the dose without guidance.

Maintenance Timing, Missed Doses, and Monitoring

After intravenous induction, the on-body injector is used at the maintenance timepoints in the official labeling. Follow the schedule provided by your care team. Do not change the interval, use extra doses, or switch devices without clinical direction, because biologic dosing is based on disease indication and treatment phase.

If a maintenance dose is missed, follow the official label or contact your clinician for individualized instructions. In many cases, delayed doses are handled by taking the missed dose as soon as feasible and returning to the planned schedule, but your care team should guide timing if the gap is long or symptoms have changed. Use calendar reminders, refill alerts, and travel planning to reduce missed-dose risk.

Monitoring may include symptom tracking, infection screening, and lab work based on your clinical history. Tell your care team if you develop persistent fever, worsening cough, unexplained weight loss, severe abdominal pain, or signs of infection. Also report new skin symptoms, allergic-type reactions, or changes in other immune conditions.

Storage, Travel, and Handling

Store the prefilled cartridge in the refrigerator in its original carton to protect it from light. Do not freeze it, and do not shake it. Keep it away from children and pets. Before use, follow the time and temperature instructions in the official device materials, because cold-chain medicines can be damaged by improper storage.

For travel, keep the carton in an insulated bag with cool packs, but do not place the medicine directly on ice. Carry the device and supplies in hand luggage when flying, along with treatment documentation if your clinician provides it. Avoid leaving the medicine in a car, checked baggage, or any location exposed to heat or freezing temperatures.

Used on-body injectors and cartridges should go into an FDA-cleared sharps container or another puncture-resistant container allowed by local rules. Do not place used devices loose in household trash. When the container is about three-quarters full, follow community disposal instructions from your pharmacy, clinic, or local waste authority.

Side Effects, Warnings, and Precautions

Common side effects reported with Skyrizi may include upper respiratory symptoms, headache, fatigue, injection-site redness or pain, and certain fungal skin infections. These effects are not the only possible reactions. Keep track of symptoms after each dose, especially when starting maintenance therapy or restarting after a delay.

Serious infections can occur because this medicine affects the immune system. Seek medical help promptly for fever, chills, shortness of breath, persistent cough, painful skin lesions, burning urination, or other signs of systemic infection. Your clinician may evaluate you for tuberculosis before treatment and may consider other infection risks based on your history.

Allergic reactions are possible. Get urgent care for swelling of the face or throat, hives, severe rash, trouble breathing, or dizziness after use. Avoid live vaccines during treatment unless your healthcare professional advises otherwise. Inactivated vaccines may be considered, but timing should be discussed before starting or continuing biologic therapy.

Tell your healthcare professional about all medicines, supplements, and biologic therapies you use. Combining immune-modulating treatments can raise infection risk in some situations. Also discuss pregnancy, plans for pregnancy, and breastfeeding so potential benefits and risks can be weighed for your specific circumstances.

Comparing Skyrizi With Related Treatment Choices

Skyrizi targets IL-23, while other immune therapies may target different inflammatory pathways. The right maintenance medicine depends on diagnosis, prior response, side effect history, injection preferences, monitoring needs, and whether bowel, joint, or skin symptoms are part of your overall condition. The immunology category can help you see how immune-mediated treatments are grouped.

Device format can also influence daily life. An on-body injector may be useful for patients who prefer automated delivery at extended maintenance intervals, but it still requires setup, skin preparation, and attention during the injection. A pen or syringe may feel more familiar to some people, while IV therapies involve clinic-based administration. Discuss the practical tradeoffs before changing from one format to another.

Cost comparisons should use the exact medicine, form, and strength your treatment plan requires. A Skyrizi prefill cartridge price is not the same as a Skyrizi pen or syringe cost if the device and indication differ. The country-of-origin browsing area for Canada-sourced products may be useful when reviewing supply context across the store.

Questions to Discuss Before Starting or Continuing

Bring specific questions to your next visit so your clinician can connect the medicine to your disease pattern and treatment goals. Ask whether IL-23 inhibition fits your history, what response markers will be followed, and how long to stay on the current maintenance schedule before reassessment. If you have Crohn’s symptoms, ask which warning signs should prompt same-day contact.

• Which device and strength should I use for my maintenance dose?
• What should I do if the on-body injector does not complete the dose?
• Do I need tuberculosis screening or updated vaccines?
• Which infections or symptoms should I report right away?
• How should I time refills around travel or surgery?
• Are there medicines or supplements I should avoid combining with this therapy?

Why it matters: A clear plan for device issues, infection symptoms, and refill timing helps reduce avoidable treatment gaps.

Authoritative Sources

This content is for informational purposes only and is not a substitute for professional medical advice.